Gyroscope Therapeutics lands $148m Series C
Gyroscope Therapeutics, a gene therapy company, has raised $148 million in Series C financing.
Gyroscope Therapeutics, a gene therapy company, has raised $148 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination